Intervacc is trading at SEK 1.17 (6.1% down) today, extending its recent downward trend amid broader biotech sector weakness and risk-off sentiment.

  • There is no fresh company-specific news or regulatory filings explaining the current move.
  • The decline appears driven by a general risk-off sentiment toward smaller, unprofitable biotech names, which can amplify volatility in stocks like Intervacc.